Supporting exposomics research with the Orbitrap Exploris GC 240 mass spectrometer

CASE STUDY 10750 Versatile, highly sensitive and reproducible: How Orbitrap Exploris GC 240 strengthens metabolomics Introduction Over the last decade, metabolomics has demonstrated immense potential in accelerating biomarker research in human health and disease. The metabolome, influenced by both genetic…

Integrating workflows and Bioinformatics for Exposome and Environmental Health Research ADVANCING EXPOSOMICS RESEARCH EXPOSOMICS AND ENVIRONMENTAL HEALTH RESEARCH Agilent empowers exposome and environmental health research with leading analytical products and solutions across omics technologies. This enables a deeper understanding of…

Using the Blood Exposome to Discover Causes of Disease Technical Overview Clinical Research Authors Introduction Stephen M. Rappaport, Ph.D. Of the 52.8 million world-wide deaths in 2010, approximately two-thirds were caused by chronic diseases, mainly cardiovascular disease (> 15 million)…

TRANSFORMING TOXICOLOGY WITH INTEGRATED MULTI-OMIC SOLUTIONS SYSTEMS TOXICOLOGY SOLUTIONS With leading analytical products across the four major omics—genomics, transcriptomics, proteomics, and metabolomics—Agilent empowers research toxicologists who are moving from traditional high-dose testing in animals to integrated systems toxicology approaches that…